Opioid Agonist [EPC]

Opioid Agonist [EPC] was reported 271858 times

Drugs of the Opioid Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 C-REACTIVE PROTEIN 511 0.5512
1 FACET JOINT SYNDROME 1705 0.5232
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 1033 0.5157
3 DUODENAL ULCER PERFORATION 3311 0.4448
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 290 0.4341
5 LUPUS VULGARIS 541 0.4294
6 RHEUMATIC FEVER 1888 0.4231
7 SWOLLEN JOINT COUNT INCREASED 1311 0.4107
8 MUSCLE INJURY 3376 0.4070
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 832 0.4012
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2849 0.3972
11 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2531 0.3893
12 FOLLICULITIS 3894 0.3710
13 DISLOCATION OF VERTEBRA 837 0.3666
14 ANAESTHETIC COMPLICATION NEUROLOGICAL 322 0.3554
15 X-RAY ABNORMAL 608 0.3397
16 HELICOBACTER INFECTION 3287 0.3195
17 PERIPHERAL VENOUS DISEASE 1306 0.3195
18 RETINITIS 520 0.3008
19 C-REACTIVE PROTEIN ABNORMAL 1846 0.2875
20 MATERNAL EXPOSURE DURING DELIVERY 280 0.2825
21 DRUG DIVERSION 1639 0.2651
22 RHEUMATOID FACTOR POSITIVE 1515 0.2620
23 PEMPHIGUS 3268 0.2611
24 DELAYED RECOVERY FROM ANAESTHESIA 242 0.2553
25 HAND DEFORMITY 3322 0.2530
26 SERONEGATIVE ARTHRITIS 258 0.2251
27 ACCIDENTAL DEATH 395 0.2124
28 PORPHYRIA ACUTE 301 0.2098
29 SYNOVITIS 3778 0.2093
30 COUNTERFEIT PRODUCT ADMINISTERED 267 0.2048
31 DRUG ABUSE 16539 0.1985
32 PERICARDITIS 3315 0.1971
33 BREAST CANCER STAGE III 1238 0.1910
34 LIP DRY 1691 0.1860
35 IRRITABLE BOWEL SYNDROME 3965 0.1847
36 PRODUCT COUNTERFEIT 314 0.1818
37 BONE EROSION 601 0.1698
38 HYPERTHERMIA MALIGNANT 249 0.1672
39 BURSITIS 2001 0.1648
40 RESPIRATORY DEPRESSION 2012 0.1640
41 GLOSSODYNIA 3575 0.1595
42 WOUND INFECTION 1701 0.1552
43 JOINT RANGE OF MOTION DECREASED 2066 0.1539
44 ONYCHOMADESIS 643 0.1531
45 BRADYPNOEA 410 0.1518
46 LIVE BIRTH 1228 0.1466
47 LEARNING DISABILITY 758 0.1422
48 FEMALE GENITAL TRACT FISTULA 234 0.1369
49 HYPERCHOLESTEROLAEMIA 1319 0.1365
50 IMPAIRED HEALING 4418 0.1344
51 WOUND 3746 0.1339
52 GRIP STRENGTH DECREASED 1173 0.1331
53 NEPHROGENIC ANAEMIA 610 0.1316
54 BLEPHAROSPASM 828 0.1314
55 DRUG USE DISORDER 1096 0.1302
56 HYPERPARATHYROIDISM SECONDARY 325 0.1296
57 ENTHESOPATHY 201 0.1284
58 DRUG TOLERANCE DECREASED 358 0.1274
59 OSTEOSCLEROSIS 199 0.1263
60 EXPOSURE VIA INGESTION 315 0.1248
61 HOMICIDE 228 0.1236
62 SUBSTANCE USE DISORDER 388 0.1217
63 AUTOIMMUNE DISORDER 1178 0.1207
64 CONTRAINDICATED PRODUCT ADMINISTERED 3507 0.1157
65 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 715 0.1157
66 FIBROMYALGIA 2809 0.1154
67 RESPIRATORY ACIDOSIS 438 0.1113
68 DRUG TOLERANCE 563 0.1112
69 INADEQUATE ANALGESIA 920 0.1082
70 CANCER PAIN 276 0.1079
71 RADICULOPATHY 282 0.1069
72 RESPIRATORY RATE DECREASED 333 0.1059
73 SYSTEMIC LUPUS ERYTHEMATOSUS 3754 0.1057
74 ONYCHOMYCOSIS 463 0.1054
75 MIOSIS 840 0.1046
76 SEROTONIN SYNDROME 2001 0.1041
77 MATERNAL EXPOSURE TIMING UNSPECIFIED 387 0.1029
78 SEDATION COMPLICATION 262 0.1026
79 BREAKTHROUGH PAIN 237 0.1024
80 SUBSTANCE ABUSE 825 0.1013
81 RESPIRATORY ARREST 2750 0.0997
82 SCIATICA 1556 0.0975
83 DEVELOPMENTAL DELAY 874 0.0968
84 LOWER RESPIRATORY TRACT INFECTION 4372 0.0960
85 EXOSTOSIS 858 0.0939
86 OBESITY 1491 0.0935
87 HYPERAESTHESIA 750 0.0912
88 NAIL DISORDER 794 0.0907
89 PULSELESS ELECTRICAL ACTIVITY 377 0.0901
90 FINGER DEFORMITY 434 0.0895
91 HYPERCAPNIA 269 0.0892
92 REBOUND ACID HYPERSECRETION 267 0.0882
93 TENOSYNOVITIS 243 0.0880
94 HYPOVENTILATION 286 0.0877
95 POISONING 1098 0.0873
96 ANAESTHETIC COMPLICATION 232 0.0863
97 DEAFNESS NEUROSENSORY 282 0.0857
98 BACK INJURY 931 0.0855
99 RED BLOOD CELL SEDIMENTATION RATE INCREASED 922 0.0832
100 CLONUS 228 0.0832
101 STOMATITIS 5051 0.0832
102 CARDIO-RESPIRATORY ARREST 3476 0.0830
103 DRUG WITHDRAWAL SYNDROME NEONATAL 1226 0.0827
104 HYPOPNOEA 287 0.0826
105 PERSONALITY DISORDER 215 0.0820
106 INFUSION SITE REACTION 243 0.0813
107 APNOEA 630 0.0808
108 DELIRIUM 2784 0.0801
109 LIVER INJURY 1963 0.0799
110 BLISTER 4485 0.0798
111 TOXICITY TO VARIOUS AGENTS 13428 0.0796
112 LOWER LIMB FRACTURE 1519 0.0790
113 PRESCRIBED OVERDOSE 1519 0.0784
114 WALKING AID USER 516 0.0782
115 DRUG DEPENDENCE 12215 0.0759
116 UNRESPONSIVE TO STIMULI 1958 0.0758
117 ARTHROPATHY 4205 0.0756
118 THERAPEUTIC PRODUCT EFFECT DECREASED 3353 0.0748
119 PROCTITIS 209 0.0745
120 TYPE 2 DIABETES MELLITUS 2507 0.0744
121 DRUG SCREEN POSITIVE 581 0.0734
122 NIGHT SWEATS 2334 0.0724
123 INFUSION RELATED REACTION 4791 0.0722
124 PSORIATIC ARTHROPATHY 2893 0.0712
125 MUSCLE SPASTICITY 870 0.0707
126 OSTEOARTHRITIS 2945 0.0694
127 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1168 0.0681
128 SPONDYLITIS 243 0.0668
129 JOINT DISLOCATION 701 0.0662
130 MYOCLONUS 788 0.0660
131 GAIT INABILITY 2201 0.0658
132 PULMONARY FIBROSIS 1251 0.0651
133 HEPATIC ENZYME INCREASED 4426 0.0649
134 COMPLETED SUICIDE 5408 0.0648
135 INJURY 4540 0.0645
136 METASTASES TO SPINE 214 0.0636
137 DRUG WITHDRAWAL SYNDROME 5545 0.0631
138 DRUG TOXICITY 859 0.0630
139 END STAGE RENAL DISEASE 1141 0.0625
140 PRODUCT LABEL CONFUSION 363 0.0622
141 BREAST CANCER STAGE II 514 0.0617
142 ATELECTASIS 590 0.0610
143 BONE LESION 217 0.0601
144 ILL-DEFINED DISORDER 3634 0.0598
145 SPINAL FUSION SURGERY 242 0.0596
146 LUPUS-LIKE SYNDROME 534 0.0588
147 ROAD TRAFFIC ACCIDENT 2440 0.0583
148 SPINAL CORD COMPRESSION 227 0.0582
149 DISCOMFORT 3512 0.0575
150 HYPOXIA 2025 0.0574
151 BRAIN OEDEMA 718 0.0568
152 HYPERREFLEXIA 198 0.0568
153 C-REACTIVE PROTEIN INCREASED 2061 0.0566
154 SUSPECTED SUICIDE 265 0.0565
155 MENTAL STATUS CHANGES 1566 0.0563
156 STRESS CARDIOMYOPATHY 327 0.0562
157 CHRONIC SINUSITIS 211 0.0562
158 FOOT DEFORMITY 622 0.0561
159 LIVER FUNCTION TEST INCREASED 1202 0.0559
160 SEDATION 1462 0.0558
161 FAILURE TO THRIVE 289 0.0556
162 MULTIPLE DRUG OVERDOSE 276 0.0556
163 SWELLING 5193 0.0554
164 CARDIAC ARREST 4578 0.0554
165 POST-TRAUMATIC STRESS DISORDER 370 0.0551
166 PATHOLOGICAL FRACTURE 280 0.0551
167 WITHDRAWAL SYNDROME 2303 0.0548
168 DEPRESSED LEVEL OF CONSCIOUSNESS 2162 0.0546
169 EPIGASTRIC DISCOMFORT 213 0.0545
170 CONFUSIONAL STATE 8761 0.0542
171 MUSCULOSKELETAL PAIN 2838 0.0541
172 COELIAC DISEASE 531 0.0541
173 NORMAL NEWBORN 293 0.0539
174 DISABILITY 1061 0.0536
175 INTERVERTEBRAL DISC DEGENERATION 491 0.0530
176 CACHEXIA 273 0.0530
177 DRUG INTOLERANCE 5099 0.0527
178 HIP ARTHROPLASTY 807 0.0526
179 JOINT SWELLING 6340 0.0525
180 OVERDOSE 11325 0.0524
181 EAR PAIN 1020 0.0524
182 TASTE DISORDER 1062 0.0523
183 BRAIN INJURY 524 0.0522
184 ASPHYXIA 426 0.0521
185 BLOOD CHOLESTEROL INCREASED 2406 0.0516
186 CONGENITAL ANOMALY 395 0.0510
187 RHEUMATOID ARTHRITIS 5763 0.0507
188 SPINAL OSTEOARTHRITIS 441 0.0501
189 INFLAMMATION 2590 0.0501
190 RASH VESICULAR 242 0.0500
191 WHITE BLOOD CELL COUNT ABNORMAL 316 0.0495
192 WHEEZING 2930 0.0494
193 DECUBITUS ULCER 396 0.0485
194 GASTROINTESTINAL DISORDER 4349 0.0485
195 GENERAL PHYSICAL HEALTH DETERIORATION 5609 0.0484
196 HYPOVOLAEMIA 283 0.0483
197 LUNG DISORDER 2352 0.0479
198 EMOTIONAL DISTRESS 5804 0.0479
199 COMPRESSION FRACTURE 256 0.0477
200 ACCIDENTAL OVERDOSE 1740 0.0475
201 BODY TEMPERATURE INCREASED 963 0.0472
202 ACUTE RESPIRATORY FAILURE 906 0.0470
203 FAECALOMA 258 0.0470
204 MOBILITY DECREASED 3382 0.0470
205 FOETAL DEATH 244 0.0470
206 SINUSITIS 4815 0.0469
207 SLEEP DISORDER 3309 0.0468
208 DIVERTICULUM INTESTINAL 205 0.0468
209 ACIDOSIS 358 0.0468
210 HEPATIC CIRRHOSIS 875 0.0465
211 ASPIRATION 509 0.0464
212 CHRONIC KIDNEY DISEASE 3517 0.0462
213 MULTI-ORGAN FAILURE 799 0.0462
214 TERMINAL STATE 309 0.0462
215 SPINAL COLUMN STENOSIS 216 0.0457
216 PRESCRIBED UNDERDOSE 911 0.0456
217 PULMONARY CONGESTION 602 0.0456
218 MATERNAL EXPOSURE DURING PREGNANCY 4066 0.0456
219 ARTERIOSCLEROSIS CORONARY ARTERY 302 0.0455
220 ENCEPHALOPATHY 1112 0.0452
221 PRODUCT ADHESION ISSUE 1600 0.0447
222 HAEMODYNAMIC INSTABILITY 341 0.0447
223 SINUS TACHYCARDIA 635 0.0447
224 SENSORY LOSS 356 0.0442
225 PULSE ABSENT 210 0.0441
226 OEDEMA 2385 0.0439
227 KNEE ARTHROPLASTY 924 0.0438
228 ANHEDONIA 1144 0.0435
229 RENAL INJURY 1291 0.0434
230 METASTASES TO BONE 712 0.0433
231 PERIPHERAL SWELLING 6660 0.0432
232 VASCULAR DEVICE INFECTION 196 0.0432
233 HYPERCALCAEMIA 529 0.0428
234 DENTAL CARIES 473 0.0427
235 MALNUTRITION 474 0.0423
236 TRICUSPID VALVE INCOMPETENCE 336 0.0422
237 CONTUSION 4056 0.0421
238 POST PROCEDURAL COMPLICATION 804 0.0418
239 ENDOMETRIOSIS 199 0.0417
240 PNEUMONIA ASPIRATION 1040 0.0416
241 OSTEOPENIA 630 0.0415
242 RESPIRATORY DISORDER 1239 0.0414
243 TOXIC ENCEPHALOPATHY 209 0.0412
244 ULCER HAEMORRHAGE 279 0.0412
245 SMALL INTESTINAL OBSTRUCTION 504 0.0409
246 IMPAIRED DRIVING ABILITY 462 0.0406
247 OXYGEN SATURATION DECREASED 2270 0.0404
248 INFECTION 5840 0.0403
249 SKIN NECROSIS 209 0.0402
250 INTENTIONAL PRODUCT USE ISSUE 3529 0.0402
251 BLOOD PRESSURE SYSTOLIC INCREASED 781 0.0400
252 APLASTIC ANAEMIA 209 0.0400
253 PROCTALGIA 257 0.0399
254 DRY MOUTH 3237 0.0399
255 COMA 1899 0.0398
256 OSTEOMYELITIS 722 0.0398
257 BACK DISORDER 648 0.0398
258 ILEUS 495 0.0398
259 ABDOMINAL TENDERNESS 197 0.0396
260 MUSCULOSKELETAL STIFFNESS 3454 0.0394
261 RENAL CYST 313 0.0394
262 LUNG INFILTRATION 348 0.0394
263 RESPIRATORY FAILURE 2867 0.0393
264 LEUKOCYTOSIS 710 0.0392
265 INTENTIONAL DRUG MISUSE 817 0.0390
266 INTESTINAL ISCHAEMIA 215 0.0390
267 PULMONARY OEDEMA 1744 0.0389
268 INCOHERENT 250 0.0386
269 PAIN 23660 0.0385
270 VENTRICULAR TACHYCARDIA 635 0.0384
271 TACHYPNOEA 522 0.0384
272 GINGIVAL PAIN 305 0.0383
273 METABOLIC ACIDOSIS 1223 0.0382
274 LIVER DISORDER 1695 0.0382
275 CARDIOMEGALY 470 0.0382
276 ACUTE PULMONARY OEDEMA 214 0.0381
277 BLOOD PRESSURE DIASTOLIC DECREASED 281 0.0380
278 ACUTE KIDNEY INJURY 5802 0.0379
279 RENAL TUBULAR NECROSIS 371 0.0378
280 EPILEPSY 1151 0.0376
281 SLEEP APNOEA SYNDROME 715 0.0374
282 SCOLIOSIS 232 0.0374
283 ACUTE RESPIRATORY DISTRESS SYNDROME 662 0.0374
284 BLOOD MAGNESIUM DECREASED 323 0.0374
285 BRONCHIECTASIS 251 0.0372
286 BRADYCARDIA 1975 0.0372
287 MUSCLE RIGIDITY 444 0.0371
288 ANAPHYLACTIC REACTION 2051 0.0371
289 TONGUE DISORDER 268 0.0370
290 SPINAL PAIN 433 0.0369
291 DIVERTICULUM 262 0.0368
292 DRUG ABUSER 226 0.0367
293 HYPERTHERMIA 280 0.0366
294 BODY TEMPERATURE DECREASED 361 0.0366
295 INTERVERTEBRAL DISC PROTRUSION 801 0.0366
296 DRUG INTERACTION 5806 0.0366
297 BLOOD ALBUMIN DECREASED 289 0.0364
298 ULCER 576 0.0362
299 POISONING DELIBERATE 343 0.0361
300 FOOD ALLERGY 278 0.0360
301 GANGRENE 217 0.0360
302 CYANOSIS 566 0.0360
303 OSTEOPOROSIS 1478 0.0359
304 RENAL FAILURE 4765 0.0358
305 IMPAIRED GASTRIC EMPTYING 489 0.0358
306 BRONCHOSPASM 511 0.0358
307 MYOSITIS 321 0.0357
308 VENTRICULAR FIBRILLATION 397 0.0357
309 SINUS BRADYCARDIA 344 0.0356
310 RIB FRACTURE 732 0.0356
311 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1707 0.0355
312 THERAPY NON-RESPONDER 1594 0.0354
313 RESPIRATORY DISTRESS 978 0.0354
314 SKIN ULCER 916 0.0354
315 MUSCULOSKELETAL CHEST PAIN 546 0.0352
316 URINARY RETENTION 1176 0.0352
317 SPINAL COMPRESSION FRACTURE 291 0.0352
318 COAGULOPATHY 586 0.0351
319 ORAL CANDIDIASIS 463 0.0351
320 TROPONIN INCREASED 267 0.0351
321 NERVE INJURY 389 0.0350
322 FREQUENT BOWEL MOVEMENTS 945 0.0349
323 NEURALGIA 849 0.0349
324 PSYCHOLOGICAL TRAUMA 301 0.0348
325 FEBRILE NEUTROPENIA 2313 0.0348
326 FLANK PAIN 325 0.0346
327 EXPOSURE DURING PREGNANCY 2140 0.0344
328 NECK PAIN 1919 0.0343
329 EMPHYSEMA 346 0.0343
330 HOSPICE CARE 338 0.0342
331 AMNESIA 2226 0.0342
332 ADVERSE REACTION 453 0.0341
333 ABDOMINAL DISCOMFORT 5686 0.0339
334 CLOSTRIDIUM DIFFICILE COLITIS 359 0.0338
335 FEAR 910 0.0338
336 TREATMENT FAILURE 2793 0.0337
337 HYPOTHERMIA 341 0.0336
338 PROTHROMBIN TIME PROLONGED 201 0.0336
339 LYMPHOEDEMA 232 0.0335
340 SPINAL DISORDER 317 0.0334
341 TENDERNESS 348 0.0334
342 MOTOR DYSFUNCTION 340 0.0333
343 BACTERAEMIA 395 0.0332
344 MEDICATION ERROR 1845 0.0332
345 HYPOTENSION 6653 0.0331
346 PNEUMOTHORAX 523 0.0329
347 HYPOKALAEMIA 1520 0.0329
348 METASTASES TO LYMPH NODES 222 0.0329
349 HIATUS HERNIA 424 0.0327
350 METASTASES TO LUNG 378 0.0327
351 ARTERIOSCLEROSIS 307 0.0326
352 MITRAL VALVE INCOMPETENCE 368 0.0325
353 GASTROOESOPHAGEAL REFLUX DISEASE 2617 0.0325
354 LEFT VENTRICULAR DYSFUNCTION 217 0.0324
355 MYDRIASIS 415 0.0323
356 TUBULOINTERSTITIAL NEPHRITIS 606 0.0323
357 PREGNANCY 646 0.0322
358 TACHYCARDIA 2866 0.0322
359 HYDRONEPHROSIS 241 0.0322
360 ECONOMIC PROBLEM 487 0.0321
361 HYPOAESTHESIA 4791 0.0320
362 TORSADE DE POINTES 251 0.0320
363 LARGE INTESTINE PERFORATION 222 0.0319
364 MULTIPLE ORGAN DYSFUNCTION SYNDROME 904 0.0319
365 BLOOD POTASSIUM INCREASED 518 0.0319
366 IMMUNODEFICIENCY 474 0.0318
367 SUPRAVENTRICULAR TACHYCARDIA 304 0.0317
368 PRE-EXISTING CONDITION IMPROVED 198 0.0317
369 PROCEDURAL COMPLICATION 243 0.0317
370 DEPENDENCE 1735 0.0316
371 SEPSIS 3522 0.0315
372 PULMONARY HAEMORRHAGE 246 0.0314
373 MIGRAINE 2992 0.0313
374 HYPERKALAEMIA 1099 0.0313
375 BLOOD CALCIUM DECREASED 352 0.0313
376 MUCOSAL INFLAMMATION 817 0.0312
377 CONSTIPATION 6788 0.0311
378 JOINT STIFFNESS 815 0.0310
379 NASOPHARYNGITIS 5721 0.0310
380 SPINAL FRACTURE 621 0.0310
381 CIRCULATORY COLLAPSE 527 0.0309
382 HYPERSENSITIVITY 5737 0.0309
383 EUPHORIC MOOD 315 0.0307
384 HYPOALBUMINAEMIA 239 0.0307
385 IMPAIRED QUALITY OF LIFE 441 0.0306
386 PLEURAL EFFUSION 1866 0.0306
387 BEDRIDDEN 403 0.0306
388 SICKLE CELL ANAEMIA WITH CRISIS 482 0.0306
389 UPPER RESPIRATORY TRACT INFECTION 1411 0.0305
390 CARDIAC MURMUR 264 0.0305
391 DISORIENTATION 1208 0.0305
392 ASCITES 894 0.0304
393 CELLULITIS 1527 0.0303
394 HYPOPHAGIA 774 0.0302
395 DISSEMINATED INTRAVASCULAR COAGULATION 426 0.0302
396 PAROSMIA 228 0.0302
397 URINE OUTPUT DECREASED 264 0.0302
398 TOOTH FRACTURE 332 0.0301
399 SOMNOLENCE 6060 0.0301
400 PULMONARY MASS 448 0.0300
401 WEIGHT INCREASED 6686 0.0298
402 ADRENAL INSUFFICIENCY 362 0.0298
403 POSTOPERATIVE WOUND INFECTION 201 0.0297
404 PYREXIA 10295 0.0297
405 HYPERHIDROSIS 3832 0.0297
406 RESPIRATORY RATE INCREASED 264 0.0297
407 CANDIDA INFECTION 501 0.0296
408 RHINITIS 239 0.0296
409 HYPERTENSION 6274 0.0296
410 QUALITY OF LIFE DECREASED 397 0.0296
411 BONE DISORDER 539 0.0295
412 CYST 366 0.0295
413 ECCHYMOSIS 202 0.0294
414 WEIGHT FLUCTUATION 308 0.0294
415 PLASMA CELL MYELOMA 1148 0.0294
416 DRUG LEVEL INCREASED 487 0.0294
417 NEUTROPENIC SEPSIS 210 0.0294
418 INTENTIONAL PRODUCT MISUSE 2573 0.0294
419 RECTAL HAEMORRHAGE 1261 0.0293
420 ANAL INCONTINENCE 264 0.0293
421 CARDIOGENIC SHOCK 421 0.0293
422 DEEP VEIN THROMBOSIS 1905 0.0293
423 ACCIDENT 350 0.0293
424 DECREASED APPETITE 6804 0.0293
425 VOMITING 13705 0.0291
426 BLOOD PRESSURE FLUCTUATION 699 0.0291
427 EATING DISORDER 620 0.0291
428 HYPOPHOSPHATAEMIA 214 0.0289
429 METASTASES TO LIVER 507 0.0288
430 OEDEMA PERIPHERAL 3507 0.0287
431 PELVIC FRACTURE 224 0.0287
432 DYSARTHRIA 1082 0.0287
433 MALIGNANT NEOPLASM PROGRESSION 2942 0.0287
434 GROIN PAIN 252 0.0287
435 ANKYLOSING SPONDYLITIS 377 0.0286
436 OBSTRUCTIVE AIRWAYS DISORDER 317 0.0285
437 HAEMATOCRIT DECREASED 565 0.0285
438 BACK PAIN 6618 0.0285
439 DEPRESSION 6473 0.0284
440 MUSCULAR WEAKNESS 3231 0.0284
441 COLITIS 1077 0.0284
442 DYSPEPSIA 2793 0.0284
443 INCONTINENCE 300 0.0284
444 ABDOMINAL PAIN 6594 0.0283
445 NEUROTOXICITY 496 0.0283
446 ROTATOR CUFF SYNDROME 363 0.0282
447 ARTHRITIS 2222 0.0282
448 HEPATITIS 722 0.0282
449 PNEUMONIA 9113 0.0281
450 DEHYDRATION 3754 0.0281
451 PULMONARY HYPERTENSION 586 0.0281
452 ORAL PAIN 629 0.0281
453 FOETAL EXPOSURE DURING PREGNANCY 2283 0.0281
454 LETHARGY 1612 0.0280
455 BODY HEIGHT DECREASED 299 0.0279
456 HEPATOMEGALY 274 0.0279
457 MYOCARDIAL ISCHAEMIA 317 0.0278
458 ELECTROLYTE IMBALANCE 323 0.0278
459 DRUG-INDUCED LIVER INJURY 871 0.0277
460 METASTASES TO CENTRAL NERVOUS SYSTEM 358 0.0277
461 VENTRICULAR EXTRASYSTOLES 288 0.0277
462 HAEMATEMESIS 703 0.0277
463 AFFECTIVE DISORDER 218 0.0277
464 SEPTIC SHOCK 1206 0.0277
465 RENAL FAILURE ACUTE 1176 0.0277
466 JOINT INJURY 592 0.0277
467 SPLENOMEGALY 324 0.0276
468 ANXIETY 7871 0.0276
469 SPINAL OPERATION 340 0.0276
470 RESTLESS LEGS SYNDROME 500 0.0275
471 AGITATION 2019 0.0275
472 DIVERTICULITIS 757 0.0273
473 SHOCK HAEMORRHAGIC 222 0.0272
474 ESCHERICHIA INFECTION 224 0.0272
475 HEPATIC STEATOSIS 507 0.0272
476 MEMORY IMPAIRMENT 3724 0.0271
477 ORAL DISORDER 198 0.0270
478 LIGAMENT SPRAIN 267 0.0270
479 OESOPHAGITIS 295 0.0270
480 UROSEPSIS 249 0.0270
481 BONE PAIN 1578 0.0269
482 DEVICE ADHESION ISSUE 413 0.0269
483 NERVE COMPRESSION 248 0.0268
484 PULMONARY EMBOLISM 2546 0.0268
485 RENAL FAILURE CHRONIC 205 0.0266
486 URTICARIA 4466 0.0266
487 BLOOD ALKALINE PHOSPHATASE INCREASED 662 0.0266
488 RHABDOMYOLYSIS 1111 0.0266
489 ABDOMINAL PAIN UPPER 5472 0.0266
490 NO THERAPEUTIC RESPONSE 324 0.0265
491 POST PROCEDURAL INFECTION 216 0.0265
492 NEUTROPHIL COUNT INCREASED 271 0.0264
493 RESTLESSNESS 968 0.0264
494 HALLUCINATION, VISUAL 558 0.0264
495 MENTAL DISORDER 1148 0.0264
496 WRONG TECHNIQUE IN DRUG USAGE PROCESS 957 0.0263
497 CLOSTRIDIUM DIFFICILE INFECTION 575 0.0263
498 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 251 0.0263
499 CHEST PAIN 4870 0.0263
500 HYPOMAGNESAEMIA 366 0.0263
501 ALOPECIA 5153 0.0262
502 CONCUSSION 203 0.0262
503 HEMIPLEGIA 218 0.0262
504 HYPERSOMNIA 751 0.0262
505 ELECTROCARDIOGRAM QT PROLONGED 941 0.0261
506 UPPER GASTROINTESTINAL HAEMORRHAGE 440 0.0261
507 TOXIC EPIDERMAL NECROLYSIS 396 0.0261
508 BLOOD POTASSIUM DECREASED 784 0.0260
509 THROMBOCYTOPENIA 2908 0.0260
510 DEVICE RELATED INFECTION 400 0.0260
511 VITAMIN D DECREASED 222 0.0259
512 NEOPLASM PROGRESSION 903 0.0259
513 ACUTE HEPATIC FAILURE 354 0.0259
514 WEIGHT DECREASED 7225 0.0259
515 HEPATIC FAILURE 780 0.0258
516 HAEMORRHOIDS 502 0.0257
517 ALTERED STATE OF CONSCIOUSNESS 556 0.0256
518 WHITE BLOOD CELL COUNT INCREASED 981 0.0255
519 HYPERLIPIDAEMIA 305 0.0255
520 HEPATIC ENCEPHALOPATHY 238 0.0255
521 MASS 356 0.0254
522 INSOMNIA 6775 0.0254
523 TOOTH LOSS 527 0.0254
524 PREMATURE DELIVERY 404 0.0253
525 PULMONARY THROMBOSIS 276 0.0253
526 BLOOD BILIRUBIN INCREASED 683 0.0253
527 ELECTROCARDIOGRAM ABNORMAL 198 0.0252
528 COORDINATION ABNORMAL 352 0.0252
529 TOOTH DISORDER 557 0.0250
530 EAR INFECTION 665 0.0250
531 ARTERIAL OCCLUSIVE DISEASE 196 0.0249
532 HALLUCINATION 1879 0.0249
533 FEEDING DISORDER 505 0.0249
534 TOOTH INFECTION 328 0.0249
535 HEMIPARESIS 421 0.0248
536 DEFORMITY 232 0.0248
537 FOOT FRACTURE 470 0.0248
538 LOSS OF CONSCIOUSNESS 3176 0.0248
539 BLOOD UREA INCREASED 414 0.0247
540 SKIN LESION 678 0.0247
541 INTESTINAL OBSTRUCTION 931 0.0247
542 PANCYTOPENIA 1378 0.0246
543 ASPARTATE AMINOTRANSFERASE INCREASED 1309 0.0246
544 NEUROLEPTIC MALIGNANT SYNDROME 292 0.0246
545 BREAST CANCER METASTATIC 264 0.0246
546 CARDIOMYOPATHY 362 0.0245
547 TOOTH ABSCESS 249 0.0244
548 CHOLESTASIS 469 0.0244
549 RENAL IMPAIRMENT 2049 0.0244
550 ABSCESS 389 0.0244
551 TENDONITIS 377 0.0243
552 HYPONATRAEMIA 1369 0.0243
553 CYTOKINE RELEASE SYNDROME 487 0.0243
554 ARTHRALGIA 10085 0.0242
555 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 214 0.0242
556 ANAPHYLACTIC SHOCK 624 0.0242
557 SPUTUM DISCOLOURED 229 0.0241
558 HEART RATE DECREASED 847 0.0241
559 AFFECT LABILITY 232 0.0241
560 POST PROCEDURAL HAEMORRHAGE 280 0.0240
561 ASTHENIA 9025 0.0240
562 MUSCLE TWITCHING 553 0.0240
563 UNEVALUABLE EVENT 1814 0.0240
564 INTESTINAL PERFORATION 269 0.0239
565 ANAEMIA 4562 0.0239
566 HAEMOGLOBIN DECREASED 2454 0.0239
567 BLOOD CREATININE INCREASED 1559 0.0239
568 GENERALISED TONIC-CLONIC SEIZURE 395 0.0238
569 HYPOTONIA 238 0.0238
570 STAPHYLOCOCCAL INFECTION 784 0.0237
571 TUMOUR LYSIS SYNDROME 209 0.0237
572 HYPERBILIRUBINAEMIA 246 0.0237
573 BLOOD PRESSURE DECREASED 1577 0.0237
574 CHOLECYSTITIS 282 0.0236
575 IMPAIRED WORK ABILITY 506 0.0236
576 MUSCLE SPASMS 4329 0.0236
577 NIGHTMARE 816 0.0236
578 STATUS EPILEPTICUS 266 0.0235
579 LOCALISED INFECTION 568 0.0235
580 ALANINE AMINOTRANSFERASE INCREASED 1439 0.0234
581 SHOCK 539 0.0234
582 NAUSEA 18540 0.0234
583 POOR VENOUS ACCESS 242 0.0234
584 KIDNEY INFECTION 456 0.0232
585 PARALYSIS 332 0.0232
586 SKIN LACERATION 252 0.0232
587 NEUROPATHY PERIPHERAL 2197 0.0231
588 GALLBLADDER DISORDER 412 0.0231
589 DYSKINESIA 938 0.0231
590 FALL 7681 0.0231
591 IRON DEFICIENCY ANAEMIA 212 0.0229
592 APHASIA 693 0.0229
593 GAIT DISTURBANCE 4386 0.0229
594 CYSTITIS 729 0.0229
595 FLUID OVERLOAD 333 0.0229
596 HYPOCALCAEMIA 433 0.0229
597 WRIST FRACTURE 274 0.0228
598 LYMPHOCYTE COUNT DECREASED 403 0.0228
599 DYSPHAGIA 2159 0.0227
600 PAIN IN EXTREMITY 6699 0.0227
601 DYSPNOEA 12870 0.0227
602 RED BLOOD CELL COUNT DECREASED 650 0.0227
603 PREMATURE BABY 684 0.0227
604 BLOOD SODIUM DECREASED 427 0.0226
605 TOOTHACHE 410 0.0226
606 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1178 0.0226
607 PANCREATITIS 1192 0.0225
608 LUNG INFECTION 350 0.0225
609 NEPHROLITHIASIS 1031 0.0225
610 DISEASE PROGRESSION 2659 0.0224
611 FLUID RETENTION 1142 0.0224
612 CONDITION AGGRAVATED 6819 0.0224
613 FATIGUE 17446 0.0224
614 BASAL CELL CARCINOMA 348 0.0223
615 FACIAL PAIN 199 0.0223
616 DECREASED ACTIVITY 240 0.0222
617 DYSURIA 816 0.0221
618 PNEUMONITIS 603 0.0221
619 PAIN IN JAW 626 0.0221
620 RASH 9612 0.0220
621 LIVER FUNCTION TEST ABNORMAL 640 0.0220
622 ANKLE FRACTURE 340 0.0219
623 PARANOIA 376 0.0218
624 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 370 0.0218
625 NEPHROPATHY 203 0.0217
626 DRUG PRESCRIBING ERROR 417 0.0217
627 HAIR COLOUR CHANGES 270 0.0217
628 SINUS CONGESTION 293 0.0217
629 PARAESTHESIA 3409 0.0216
630 ASTHMA 2446 0.0216
631 CHOLELITHIASIS 709 0.0216
632 FULL BLOOD COUNT DECREASED 435 0.0216
633 BRONCHITIS 1597 0.0216
634 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1533 0.0215
635 GASTRITIS 564 0.0214
636 LACERATION 201 0.0214
637 HAEMOPTYSIS 596 0.0213
638 VAGINAL DISCHARGE 216 0.0213
639 PROSTATIC SPECIFIC ANTIGEN INCREASED 294 0.0213
640 ABDOMINAL DISTENSION 2226 0.0213
641 GASTRIC ULCER 405 0.0213
642 TRANSFUSION 223 0.0213
643 URINARY TRACT INFECTION 3624 0.0212
644 DRUG EFFECT DECREASED 1142 0.0212
645 PROCEDURAL PAIN 588 0.0212
646 URINARY INCONTINENCE 627 0.0211
647 HYPOTHYROIDISM 674 0.0211
648 COLD SWEAT 371 0.0210
649 HAEMATOMA 544 0.0210
650 EJECTION FRACTION DECREASED 326 0.0210
651 GENERALISED OEDEMA 259 0.0209
652 PERICARDIAL EFFUSION 483 0.0209
653 NODULE 272 0.0208
654 CHOLECYSTECTOMY 238 0.0208
655 MOUTH ULCERATION 438 0.0208
656 PRODUCT QUALITY ISSUE 2811 0.0207
657 ACUTE MYOCARDIAL INFARCTION 610 0.0207
658 MUSCULOSKELETAL DISCOMFORT 356 0.0207
659 COLITIS ULCERATIVE 921 0.0206
660 ORTHOSTATIC HYPOTENSION 357 0.0205
661 DIARRHOEA 13221 0.0205
662 HYPOKINESIA 297 0.0204
663 OSTEONECROSIS OF JAW 506 0.0204
664 SCAR 350 0.0204
665 GAMMA-GLUTAMYLTRANSFERASE INCREASED 453 0.0204
666 PERIPHERAL COLDNESS 280 0.0204
667 HERPES ZOSTER 1171 0.0204
668 INTERNATIONAL NORMALISED RATIO INCREASED 580 0.0203
669 UPPER LIMB FRACTURE 405 0.0203
670 HIP FRACTURE 653 0.0203
671 HYPERGLYCAEMIA 739 0.0203
672 NEOPLASM 233 0.0203
673 HAEMATOCHEZIA 1114 0.0202
674 DERMATITIS CONTACT 230 0.0201
675 FEELING COLD 561 0.0201
676 SKIN INFECTION 226 0.0201
677 BLOOD IRON DECREASED 239 0.0201
678 BLOOD LACTATE DEHYDROGENASE INCREASED 319 0.0201
679 GOUT 361 0.0201
680 DYSSTASIA 587 0.0201
681 PLATELET COUNT DECREASED 2141 0.0201
682 THROMBOSIS 1616 0.0201
683 HEAD INJURY 634 0.0200
684 COGNITIVE DISORDER 935 0.0200
685 PLATELET COUNT INCREASED 261 0.0200
686 HAEMATURIA 685 0.0200
687 IMMUNE SYSTEM DISORDER 263 0.0199
688 LOCAL SWELLING 348 0.0199
689 RETCHING 424 0.0199
690 PARAESTHESIA ORAL 286 0.0198
691 HEPATOCELLULAR INJURY 281 0.0198
692 FEELING HOT 1215 0.0198
693 CARPAL TUNNEL SYNDROME 277 0.0198
694 HERNIA 382 0.0197
695 MUSCLE ATROPHY 250 0.0197
696 MALAISE 8634 0.0197
697 HALLUCINATION, AUDITORY 312 0.0196
698 PRODUCT USE ISSUE 3686 0.0196
699 HEPATIC CYTOLYSIS 250 0.0196
700 PRODUCTIVE COUGH 934 0.0195
701 POLYNEUROPATHY 234 0.0195
702 PRODUCT PRESCRIBING ERROR 465 0.0195
703 RASH MACULO-PAPULAR 434 0.0195
704 FISTULA 219 0.0195
705 CHILLS 2282 0.0194
706 NEUTROPHIL COUNT DECREASED 793 0.0194
707 SINUS DISORDER 385 0.0194
708 PALLOR 528 0.0194
709 COVID-19 PNEUMONIA 229 0.0194
710 ATRIAL FIBRILLATION 1888 0.0194
711 APPLICATION SITE RASH 266 0.0193
712 WHITE BLOOD CELL COUNT DECREASED 2093 0.0193
713 SUBDURAL HAEMATOMA 274 0.0191
714 PANCREATITIS ACUTE 430 0.0191
715 THINKING ABNORMAL 356 0.0191
716 PRURITUS 7336 0.0191
717 BLOOD PRESSURE INCREASED 2916 0.0191
718 PETECHIAE 199 0.0191
719 RESPIRATORY TRACT CONGESTION 303 0.0191
720 ATAXIA 226 0.0190
721 BIPOLAR DISORDER 207 0.0190
722 DYSPNOEA EXERTIONAL 716 0.0190
723 SECRETION DISCHARGE 238 0.0190
724 LIMB INJURY 516 0.0190
725 DRUG ADMINISTRATION ERROR 582 0.0189
726 PANIC ATTACK 689 0.0189
727 LYMPHADENOPATHY 668 0.0189
728 BLOOD CREATINE PHOSPHOKINASE INCREASED 543 0.0188
729 HEPATOTOXICITY 419 0.0188
730 MENTAL IMPAIRMENT 456 0.0188
731 TREMOR 3118 0.0188
732 DRUG ADMINISTERED AT INAPPROPRIATE SITE 198 0.0188
733 AGGRESSION 935 0.0187
734 SKIN REACTION 263 0.0187
735 DELUSION 290 0.0186
736 THYROID DISORDER 287 0.0186
737 GASTROINTESTINAL HAEMORRHAGE 1556 0.0186
738 GASTROINTESTINAL PAIN 203 0.0184
739 ADVERSE EVENT 1700 0.0184
740 INTENTIONAL OVERDOSE 1181 0.0184
741 HEPATITIS C 222 0.0184
742 DEATH 15743 0.0183
743 TOOTH EXTRACTION 227 0.0182
744 LABORATORY TEST ABNORMAL 537 0.0182
745 LEUKOPENIA 910 0.0182
746 DISTURBANCE IN ATTENTION 981 0.0182
747 MUSCULOSKELETAL DISORDER 345 0.0181
748 SPEECH DISORDER 947 0.0181
749 SKIN HAEMORRHAGE 267 0.0180
750 CORONARY ARTERY DISEASE 544 0.0179
751 NOCTURIA 218 0.0179
752 BLOOD TEST ABNORMAL 251 0.0178
753 CRYING 646 0.0178
754 PELVIC PAIN 321 0.0177
755 BLOOD PRESSURE ABNORMAL 351 0.0176
756 ADVERSE DRUG REACTION 1584 0.0176
757 ABNORMAL BEHAVIOUR 697 0.0176
758 CHROMATURIA 397 0.0176
759 ACTIVITIES OF DAILY LIVING IMPAIRED 346 0.0175
760 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 407 0.0174
761 SUICIDE ATTEMPT 1056 0.0174
762 ANGINA PECTORIS 499 0.0174
763 MOVEMENT DISORDER 559 0.0174
764 HEADACHE 10885 0.0173
765 BALANCE DISORDER 1498 0.0173
766 RESPIRATORY TRACT INFECTION 451 0.0173
767 HEART RATE INCREASED 1714 0.0173
768 POOR QUALITY SLEEP 371 0.0172
769 EPISTAXIS 1289 0.0172
770 BLOOD URINE PRESENT 327 0.0172
771 FRACTURE 326 0.0172
772 SENSORY DISTURBANCE 275 0.0171
773 NEPHROPATHY TOXIC 192 0.0171
774 NERVOUS SYSTEM DISORDER 530 0.0170
775 GASTROENTERITIS VIRAL 306 0.0169
776 PRODUCT USE IN UNAPPROVED INDICATION 4166 0.0168
777 GASTROENTERITIS 245 0.0168
778 MYOCARDITIS 192 0.0167
779 DEVICE FAILURE 254 0.0167
780 HYPOGLYCAEMIA 808 0.0166
781 NEUTROPENIA 2265 0.0166
782 DIZZINESS 8296 0.0166
783 PHOTOSENSITIVITY REACTION 274 0.0166
784 ABASIA 409 0.0165
785 FUNGAL INFECTION 549 0.0165
786 STEVENS-JOHNSON SYNDROME 366 0.0164
787 DYSTONIA 318 0.0164
788 ABDOMINAL PAIN LOWER 414 0.0164
789 MUSCLE TIGHTNESS 265 0.0163
790 BLOOD COUNT ABNORMAL 248 0.0163
791 TINNITUS 750 0.0163
792 TRANSAMINASES INCREASED 362 0.0163
793 MACULAR DEGENERATION 194 0.0162
794 LACTIC ACIDOSIS 525 0.0162
795 RENAL DISORDER 750 0.0161
796 GASTRIC DISORDER 551 0.0160
797 FLATULENCE 909 0.0160
798 BACTERIAL INFECTION 299 0.0160
799 JAUNDICE 431 0.0160
800 OFF LABEL USE 13984 0.0160
801 RHINORRHOEA 1032 0.0160
802 FEELING ABNORMAL 3812 0.0159
803 SEASONAL ALLERGY 225 0.0159
804 PHARYNGITIS 197 0.0159
805 RASH PRURITIC 860 0.0159
806 PRODUCT PHYSICAL ISSUE 320 0.0158
807 SWOLLEN TONGUE 495 0.0158
808 BURNING SENSATION 1106 0.0158
809 PSYCHOTIC DISORDER 465 0.0157
810 THERAPEUTIC RESPONSE DECREASED 952 0.0157
811 SURGERY 917 0.0156
812 FAECES DISCOLOURED 339 0.0156
813 SUICIDAL IDEATION 1429 0.0156
814 SEIZURE 1801 0.0156
815 PSYCHOMOTOR HYPERACTIVITY 258 0.0155
816 MIDDLE INSOMNIA 289 0.0155
817 DYSPHONIA 902 0.0154
818 HOT FLUSH 1155 0.0153
819 FACE OEDEMA 258 0.0153
820 LIMB DISCOMFORT 473 0.0153
821 INFLUENZA 1701 0.0152
822 RASH ERYTHEMATOUS 727 0.0152
823 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 834 0.0152
824 SYNCOPE 1519 0.0152
825 HEART RATE IRREGULAR 343 0.0152
826 OROPHARYNGEAL PAIN 1405 0.0152
827 DRUG INEFFECTIVE 19995 0.0152
828 PRODUCT PRESCRIBING ISSUE 329 0.0151
829 HAIR TEXTURE ABNORMAL 202 0.0151
830 APPLICATION SITE PRURITUS 342 0.0151
831 DIPLOPIA 390 0.0150
832 GLAUCOMA 289 0.0150
833 SKIN DISCOLOURATION 688 0.0150
834 PRESYNCOPE 364 0.0150
835 ORAL DISCOMFORT 207 0.0149
836 SNEEZING 333 0.0148
837 VERTIGO 904 0.0148
838 ORAL HERPES 289 0.0148
839 DRUG ERUPTION 262 0.0148
840 SKIN DISORDER 492 0.0147
841 HYPOAESTHESIA ORAL 222 0.0147
842 POLLAKIURIA 612 0.0147
843 CARDIAC FAILURE CONGESTIVE 1178 0.0147
844 NERVOUSNESS 765 0.0146
845 APPLICATION SITE ERYTHEMA 380 0.0145
846 PHOTOPHOBIA 272 0.0144
847 VISUAL IMPAIRMENT 1786 0.0144
848 ARRHYTHMIA 679 0.0143
849 PHARMACEUTICAL PRODUCT COMPLAINT 371 0.0143
850 IRRITABILITY 859 0.0143
851 MELAENA 314 0.0143
852 CONVULSION 815 0.0142
853 INTERSTITIAL LUNG DISEASE 688 0.0142
854 CATARACT 843 0.0141
855 DYSGEUSIA 1045 0.0141
856 CARDIAC FAILURE 1129 0.0140
857 INFLUENZA LIKE ILLNESS 1155 0.0140
858 ANGER 473 0.0140
859 PSORIASIS 1812 0.0139
860 THIRST 247 0.0138
861 COLON CANCER 206 0.0138
862 DEMENTIA 386 0.0138
863 PHARYNGEAL OEDEMA 212 0.0138
864 HAEMORRHAGE INTRACRANIAL 206 0.0138
865 CONJUNCTIVITIS 255 0.0137
866 DIALYSIS 195 0.0137
867 TREATMENT NONCOMPLIANCE 751 0.0137
868 CEREBRAL HAEMORRHAGE 489 0.0136
869 CHEST DISCOMFORT 1385 0.0135
870 ILLNESS 1393 0.0135
871 CARDIAC DISORDER 1261 0.0135
872 MYELODYSPLASTIC SYNDROME 194 0.0134
873 MULTIPLE FRACTURES 220 0.0134
874 UNDERDOSE 976 0.0134
875 COUGH 3728 0.0133
876 VIRAL INFECTION 442 0.0133
877 PERITONITIS 272 0.0131
878 FEMUR FRACTURE 402 0.0130
879 HOSPITALISATION 1993 0.0130
880 CHOKING 251 0.0129
881 HEAD DISCOMFORT 226 0.0128
882 FEELING JITTERY 243 0.0127
883 AGEUSIA 317 0.0127
884 MOOD SWINGS 405 0.0127
885 ACUTE MYELOID LEUKAEMIA 198 0.0127
886 TRANSIENT ISCHAEMIC ATTACK 427 0.0126
887 DIABETES MELLITUS 963 0.0126
888 ERYTHEMA 2596 0.0126
889 EMOTIONAL DISORDER 389 0.0126
890 DEPRESSED MOOD 667 0.0126
891 ISCHAEMIC STROKE 225 0.0126
892 MYALGIA 2142 0.0126
893 ABNORMAL DREAMS 347 0.0126
894 SKIN FISSURES 245 0.0125
895 DRUG EFFECT INCOMPLETE 453 0.0125
896 PRURITUS GENERALISED 268 0.0124
897 THERAPY CESSATION 635 0.0124
898 HEPATIC FUNCTION ABNORMAL 461 0.0123
899 PALPITATIONS 1445 0.0123
900 PRODUCT SUBSTITUTION ISSUE 710 0.0123
901 NEOPLASM MALIGNANT 812 0.0122
902 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 313 0.0122
903 DEAFNESS 317 0.0121
904 DRY EYE 604 0.0121
905 EOSINOPHILIA 212 0.0121
906 BONE MARROW FAILURE 245 0.0120
907 CEREBROVASCULAR ACCIDENT 2037 0.0120
908 OSTEONECROSIS 394 0.0120
909 APPLICATION SITE PAIN 264 0.0120
910 DEVICE MALFUNCTION 842 0.0120
911 SWELLING FACE 780 0.0120
912 HAEMORRHAGE 1252 0.0120
913 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 850 0.0119
914 NASAL CONGESTION 698 0.0119
915 INCORRECT ROUTE OF DRUG ADMINISTRATION 424 0.0119
916 INTENTIONAL SELF-INJURY 239 0.0118
917 BONE DENSITY DECREASED 370 0.0118
918 MYOCARDIAL INFARCTION 2032 0.0116
919 VISION BLURRED 1578 0.0115
920 PROTEINURIA 217 0.0114
921 LACRIMATION INCREASED 344 0.0114
922 DIABETES MELLITUS INADEQUATE CONTROL 201 0.0113
923 PRODUCT AVAILABILITY ISSUE 256 0.0112
924 RASH GENERALISED 288 0.0111
925 RASH MACULAR 388 0.0111
926 PRODUCT ADMINISTRATION ERROR 223 0.0110
927 ANGIOEDEMA 487 0.0110
928 CEREBRAL INFARCTION 263 0.0108
929 ERECTILE DYSFUNCTION 274 0.0107
930 CARDIOVASCULAR DISORDER 267 0.0105
931 INCORRECT PRODUCT ADMINISTRATION DURATION 226 0.0104
932 DRUG DOSE OMISSION 1715 0.0104
933 HYPOACUSIS 445 0.0103
934 AGRANULOCYTOSIS 192 0.0103
935 LUNG NEOPLASM MALIGNANT 424 0.0103
936 PANCREATIC CARCINOMA 296 0.0102
937 SKIN EXFOLIATION 859 0.0102
938 DERMATITIS 213 0.0102
939 MOOD ALTERED 276 0.0101
940 THROAT TIGHTNESS 273 0.0101
941 LIP SWELLING 336 0.0101
942 THERAPEUTIC RESPONSE UNEXPECTED 452 0.0101
943 FLUSHING 1017 0.0100
944 RASH PAPULAR 224 0.0100
945 THROAT IRRITATION 446 0.0099
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1790 0.0099
947 PRODUCT DOSE OMISSION 637 0.0097
948 INTENTIONAL DOSE OMISSION 278 0.0097
949 EXTRAPYRAMIDAL DISORDER 242 0.0097
950 EYE DISORDER 318 0.0097
951 COVID-19 1678 0.0096
952 INJECTION SITE REACTION 657 0.0095
953 THERAPY INTERRUPTED 679 0.0095
954 INCORRECT DRUG ADMINISTRATION DURATION 260 0.0092
955 BLINDNESS 367 0.0090
956 EYE SWELLING 330 0.0089
957 EYE PAIN 484 0.0086
958 BLOOD GLUCOSE DECREASED 401 0.0083
959 ECZEMA 436 0.0083
960 VISUAL ACUITY REDUCED 266 0.0080
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1579 0.0078
962 MULTIPLE SCLEROSIS RELAPSE 533 0.0078
963 DRY SKIN 1022 0.0076
964 MULTIPLE SCLEROSIS 365 0.0076
965 PRODUCT DOSE OMISSION IN ERROR 216 0.0076
966 PRODUCT DOSE OMISSION ISSUE 2217 0.0075
967 OCULAR HYPERAEMIA 351 0.0074
968 THERAPEUTIC RESPONSE SHORTENED 244 0.0074
969 VAGINAL HAEMORRHAGE 315 0.0073
970 INCORRECT DOSE ADMINISTERED 1618 0.0071
971 BLOOD GLUCOSE INCREASED 1318 0.0070
972 DRUG EXPOSURE DURING PREGNANCY 232 0.0068
973 DEVICE DISLOCATION 286 0.0066
974 INJECTION SITE MASS 235 0.0063
975 DISEASE RECURRENCE 298 0.0063
976 EXPIRED PRODUCT ADMINISTERED 202 0.0061
977 DEVICE ISSUE 528 0.0059
978 INJECTION SITE BRUISING 463 0.0058
979 SKIN IRRITATION 242 0.0053
980 EXTRA DOSE ADMINISTERED 209 0.0052
981 INJECTION SITE PAIN 1550 0.0050
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 230 0.0049
983 EYE IRRITATION 275 0.0048
984 ACCIDENTAL EXPOSURE TO PRODUCT 468 0.0045
985 ACNE 332 0.0044
986 INJECTION SITE PRURITUS 289 0.0043
987 INJECTION SITE ERYTHEMA 534 0.0043
988 INJECTION SITE HAEMORRHAGE 337 0.0042
989 PROSTATE CANCER 335 0.0042
990 BREAST CANCER 350 0.0038
991 SKIN BURNING SENSATION 262 0.0037
992 NO ADVERSE EVENT 647 0.0036
993 INJECTION SITE SWELLING 266 0.0035